Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis

Blood Cancer Journal, Published online: 23 December 2022; doi:10.1038/s41408-022-00776-5Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis

https://www.nature.com/articles/s41408-022-00776-5

Source: Blood Cancer Journal - December 23, 2022 Category: Hematology Authors: Noppacharn Uaprasert Palada Pitakkitnukun Nuanrat Tangcheewinsirikul Thita Chiasakul Ponlapat Rojnuckarin Source Type: research